Cas 359880-66-3,2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide

359880-66-3

Post Buying Request

Basic information

Product Name: 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide
Synonyms: 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide
CAS NO:359880-66-3
Molecular Formula:
Molecular Weight: 396.53
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide(CAS DataBase Reference)
NIST Chemistry Reference: 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide(359880-66-3)
EPA Substance Registry System: 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)-acetamide(359880-66-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 359880-66-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

359880-66-3 Suppliers

Recommended suppliers

359880-66-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 359880-66-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,8,8 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 359880-66:
(8*3)+(7*5)+(6*9)+(5*8)+(4*8)+(3*0)+(2*6)+(1*6)=203
203 % 10 = 3
So 359880-66-3 is a valid CAS Registry Number.

359880-66-3Upstream product

359880-66-3Downstream Products

359881-88-2 2-(3,4-dimethoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)acetamide hydrochloride

359880-66-3Relevant academic research and scientific papers

USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS

-

Page/Page column 147-148, (2010/11/28)

Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 359880-66-3